6 Followers on Owler
OverviewCompetitorsFundingNews & Insights

A2 Bio Competitors or Alternatives

A2 Bio's top competitors include Triumvira, Neogene and NexImmune.

Unlock 19 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

A2 Bio's company profile

James Robinson

CEO

83/100
100 - 250
$287.6M
$5M - 25M
  • $287.6M
    $5M - 25M
  • 100 - 250
    $287.6M
  • $5M - 25M
  • 83/100
  • 100 - 250
  • $287.6M
  • $5M - 25M
View ProfileView
1
A2 Bio's Competitor - Triumvira logo

Paul Lammers

President & CEO

90/100
25 - 100
$124.7M
$5M - 25M
  • $124.7M
    $5M - 25M
  • 25 - 100
    $124.7M
  • $5M - 25M
  • 90/100
  • 25 - 100
  • $124.7M
  • $5M - 25M
View ProfileView
2
A2 Bio's Competitor - Neogene logo

Carsten Linnemann

Co-Founder & CEO

86/100
1 - 25
$125M
$100K - 5M
  • $125M
    $100K - 5M
  • 1 - 25
    $125M
  • $100K - 5M
  • 86/100
  • 1 - 25
  • $125M
  • $100K - 5M
View ProfileView
3
A2 Bio's Competitor - NexImmune logo

Kristi Jones

CEO

86/100
6
$166.4M
  • $166.4M
  • 6
    $166.4M
  • 86/100
  • 6
  • $166.4M
View ProfileView
4
A2 Bio's Competitor - Inovio logo

Jacqueline Shea

President & CEO

47/100
320
$296.4M
$ < 1M
  • $296.4M
    $ < 1M
  • 320
    $296.4M
  • $ < 1M
  • 47/100
  • 320
  • $296.4M
  • $ < 1M
View ProfileView
5
A2 Bio's Competitor - Agenus logo

Garo H. Armen

Chairman & CEO

85/100
440
$352.2M
$103.5M
  • $352.2M
    $103.5M
  • 440
    $352.2M
  • $103.5M
  • 85/100
  • 440
  • $352.2M
  • $103.5M
View ProfileView
A2 Bio's top 22 competitors are Triumvira, Neogene, NexImmune, bluebird bio, Inovio, Agenus, VBI, RAPT, Jounce, Peloton Therapeutics, Juno Therapeutics, Arecor, Kite Pharma, PaxVax, Novartis, Amgen, Excelsior Solutions, CR Pharmaceutical, CPP, Pfizer, Takeda Pharmaceutical and Sangamo. Together they have raised over 18.8B between their estimated 311.9K employees. A2 Bio's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 9.7B. A2 Bio has 140 employees and is ranked 14th among it's top 10 competitors. The top 10 competitors average 13,566.

A2 Bio VS Triumvira

Triumvira is A2 Bio's biggest rival. Triumvira was founded in 2015, and is headquartered in Austin, Texas. Like A2 Bio, Triumvira also works within the Pharmaceuticals & Biotechnology sector. Triumvira generates $600K less revenue vs. A2 Bio.

A2 Bio VS Neogene

Neogene is one of A2 Bio's top competitors. Neogene's headquarters is in Santa Monica, California, and was founded in 2018. Like A2 Bio, Neogene also works within the Biotechnology sector. Neogene generates 22% of A2 Bio's revenue.

A2 Bio VS NexImmune

NexImmune is seen as one of A2 Bio's top competitors. NexImmune is a Public company that was founded in 2011 in Gaithersburg, Maryland. NexImmune operates in the Biotechnology industry. Compared to A2 Bio, NexImmune has 134 fewer employees.

Looking for similar companies to A2 Bio?

Similar Companies

Companies in Agoura Hills with employees in 100-250 range

See 74 companies 
Biotechnology companies in Los Angeles Metropolitan Area

See 673 companies 
Companies in Agoura Hills with revenue in $5.0-25M range

See 286 companies 
Pharmaceuticals & Biotechnology companies in Los Angeles Metropolitan Area

See 1,043 companies 
Biotechnology companies with employees in 100-250 range

See 1,110 companies 
Pharmaceuticals & Biotechnology companies with employees in 100-250 range

See 1,805 companies 
Biotechnology companies in California

See 3,096 companies 
Biotechnology companies with revenue in $5.0-25M range

See 3,620 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,181 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for A2 Bio and A2 Bio's Competitors

April 17, 2025Benzinga
CDC panel expands Pfizer and GSK RSV vaccine use to high-risk adults 50-59, building on earlier recommendations for older populations. read more...
April 17, 2025Bloomberg Law
A three-judge panel wrestled Thursday with Novartis AG's challenge against the FDA over its approval of a generic version of its heart failure drug, pr...
April 17, 2025Openpr
Skin Cancer Drugs Market is estimated to be valued at USD 10.3 Bn in 2025 and is expected to reach USD 18.00 Bn in 2032, exhibiting a compound annual g...
April 18, 2025Openpr
Asthma And COPD Market is estimated to be valued at USD 38.73 Bn in 2025 and is expected to reach USD 54.13 Bn in 2032, exhibiting a compound annual gr...
April 17, 2025Seeking Alpha
April 17, 2025Seeking Alpha
April 18, 2025Openpr
HTF MI just released the Global Lifestyle Drugs Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the ...
April 18, 2025Openpr
The Oncogene Market is anticipated to grow at a CAGR of 9.4% between 2025 and 2032, reaching an estimated USD 12.8 billion by 2032, up from USD 6.5 bil...
April 17, 2025Seeking Alpha
April 17, 2025Openpr
Skin Cancer Drugs Market is estimated to be valued at USD 10.3 Bn in 2025 and is expected to reach USD 18.00 Bn in 2032, exhibiting a compound annual g...

Frequently Asked Questions about A2 Bio

  1. Who are A2 Bio's top competitors?

    A2 Bio's top 3 competitors are Triumvira, Neogene, NexImmune.

  2. Who is similar to A2 Bio?

    Triumvira is the most similar to A2 Bio. Neogene and NexImmune are also similar to A2 Bio.

  1. Are A2 Bio and Triumvira competitors?

    Yes, Triumvira is one of A2 Bio’s top competitors.